Boston Scientific

Massachusetts
Health Care Equipment and Services

Corprate Bias Ratings

Risk Level:

Rating - Danger
High Risk

Boston Scientific scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with Human Rights Campaign's controversial demands, Boston Scientific increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Boston Scientific forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Boston Scientific is a corporate partner of the Human Rights Campaign (HRC) and pledged $3.5 million to BLM and related causes. The company supports the Equality Act and regularly uses its corporate reputation to advance gender ideology. Boston Scientific's CEO signed the CEO Action for Diversity & Inclusion pledge and the CEO Action for Racial Equity pledge. The company has donated to the Equality PAC and lobbied for the Equality Act. Boston Scientific opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Boston Scientific receives a High Risk rating.

Criteria
Risk Level
Rationale
Corporate Weaponization
Criteria

Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level
Rationale

Boston Scientific received a score of 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. The company recruits employees based on sexual identity issues. The company discriminates against vendors that do not promote divisive sex and gender policies, indicating it prioritizes sexual issues over merit (1)(2). However, the company has not publicly terminated business relationships due to political views or religious beliefs.

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level
Rationale

Boston Scientific’s HRC CEI rating indicates the company will not donate to non-religious charities unless they embrace controversial sexual identity policies (1)(2).

Criteria

Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.

Risk Level
Rationale

Boston Scientific‘s HRC 2023 CEI rating indicates the company forces employees to attend multiple, controversial trainings on gender identity, sexual orientation, transgender issues, and divisive racial ideology. The company provides gender transition guidelines for its employees and a specific benefits guide with a comprehensive explanation of transgender services funded by the company (1)(2). Boston Scientific’s CEO signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace (3). The company does not provide viewpoint protections for its employees (4).

Corporate Governance and Public Policy
Criteria

Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.

Risk Level
Rationale

Boston Scientific‘s HRC 2023 CEI rating indicates the company agrees to allow a controversial stakeholder group focused on sexual identity issues to dictate marketing or advertising strategy (1)(2). By doing so, the company risks dividing employees, alienating customers and harming shareholders. Boston Scientific signed an open letter in support of the Equality Act and is a member of America Competes National Business Coalition for Nondiscrimination (3)(4). Boston Scientific was part of the Freedom for All Americans coalition, which advocated for federal legislation to overrule state laws designed to protect girls’ sports and similar laws (5). The company used its social media platform to “urge Congress” to pass left-wing voting reform legislation (6). In late 2020, Boston Scientific paid for “anti-racism” billboards that bore the company’s name around the city of Boston (7). The company’s CEO also signed the CEO Action for Racial Equity, which supports legislative and social left-wing movements (8). Boston Scientific opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces (9)(10). The company opposed the Florida Parental Rights in Education Act, which would prohibit teaching gender identity and sexual orientation to kids in K-3rd grade (11).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

Boston Scientific‘s HRC 2023 CEI rating indicates the company covers transgender related costs for its employees and their children, including paid short-term leave, puberty blockers, cross-sex hormones, chest surgeries, genital surgeries, medical visits and lab monitoring, travel and lodging. Additionally, the company has pledged philanthropic support of at least one organization or event that promotes sex and gender ideology (1)(2). By allowing a political stakeholder group to dictate operations, the company increases health care costs and risks dividing employees, alienating customers and harming shareholders. Boston Scientific has pledged $3.5 million to the Black Lives Matter movement and related causes (3)(4). The company is a bronze partner of the HRC (5). Boston Scientific sponsors company-wide Gay and Lesbian Alliance Against Defamation (GLAAD) events and is a corporate partner of the National LGBT Chamber of Commerce (NGLCC) (6)(7).

Criteria

Uses corporate political contributions for ideological, non-business purposes.

Risk Level
Rationale

Boston Scientific‘s HRC 2023 CEI rating indicates the company publicly advocated for controversial sex and gender ideology through local, state or federal legislation or initiatives (1)(2). By allowing a political stakeholder group to dictate operations, the company risks dividing employees, alienating customers and harming shareholders. Boston Scientific has donated to the Equality PAC and lobbied for the Equality Act (3)(4)(5).

All links were last accessed and all information was updated on:
March 25, 2024

Company reports are intended for educational use only. Full Disclaimer

Generate Reports
Clear
Toast

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

Accept